APA (7th ed.) Citation

Martin-Facklam, M., Rengelshausen, J., Tayrouz Haffar, Y. A., Ketabi-Kiyanvash, N., Lindenmaier, H., Schneider, V. J., . . . Haefeli, W. E. (2005). Dose individualisation in patients with renal insufficiency: Does drug labelling support optimal management? European journal of clinical pharmacology, 60(11), . https://doi.org/10.1007/s00228-004-0852-y

Chicago Style (17th ed.) Citation

Martin-Facklam, Meret, Jens Rengelshausen, Yorki Antoine Tayrouz Haffar, Nahal Ketabi-Kiyanvash, Heike Lindenmaier, Verena Janina Schneider, Verena Bergk, and Walter E. Haefeli. "Dose Individualisation in Patients with Renal Insufficiency: Does Drug Labelling Support Optimal Management?" European Journal of Clinical Pharmacology 60, no. 11 (2005). https://doi.org/10.1007/s00228-004-0852-y.

MLA (9th ed.) Citation

Martin-Facklam, Meret, et al. "Dose Individualisation in Patients with Renal Insufficiency: Does Drug Labelling Support Optimal Management?" European Journal of Clinical Pharmacology, vol. 60, no. 11, 2005, https://doi.org/10.1007/s00228-004-0852-y.